title: [Loperamide for acute infectious diarrhoea].
abstract: Many physicians are resistant to the idea of prescribing loperamide for acute infectious traveller's diarrhoea and community-acquired diarrhoea because of the fear of possible adverse effects. Large randomized trials with loperamide, either alone or as an adjunct to antibiotic treatment, have in fact revealed positive rather than negative effects. International guidelines now often support the use of loperamide for the treatment of infectious diarrhoea without dysentery. There seems to be no reason to systematically avoid loperamide in patients with dysentery, but caution is advised. Loperamide can be used as monotherapy or as an adjunct to antibiotic treatment in immunocompetent adults with acute infectious traveller's diarrhoea or community-acquired diarrhoea without severe comorbidities. This can reduce both the frequency of diarrhoea and the time until the diarrhoea stops without the risk of severe complications.
authors.affiliation: VU medisch centrum, afd. Interne Geneeskunde, Amsterdam.
authors.forename: Joeri A J
authors.initials: JA
authors.lastname: Douma
authors.forename: Yvo M
authors.initials: YM
authors.lastname: Smulders
mesh_terms: D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000930:Antidiarrheals / Q000009:adverse effects / Q000627:therapeutic use*; D003141:Communicable Diseases / Q000188:drug therapy; D003967:Diarrhea / Q000188:drug therapy*; D004403:Dysentery / Q000188:drug therapy*; D006801:Humans; D008139:Loperamide / Q000009:adverse effects / Q000627:therapeutic use*; D014195:Travel
chemical_list: D000900:Anti-Bacterial Agents; D000930:Antidiarrheals; D008139:Loperamide